Skip to main content
. 2021 Jun 24;9(7):1375. doi: 10.3390/microorganisms9071375

Figure 3.

Figure 3

(a) Dose response curves of peripheral blood mononuclear cells from four representative donors, C162–165 (n = 10), treated with Shigella four-component GMMA drug product (DP) stored at 4 °C (black inverted triangles), 25 °C (pink diamonds) or 40 °C for 3 months. The highest concentration of Shigella four-component GMMA DP was 12.5 ng/mL for donors C162, 164 and 165, and 3.125 ng/mL for donor C163. A two-way ANOVA (p > 0.05) was carried out on OD values for statistical analysis. (b) Half maximal effective dose (EC50) values from the interleukin-6 response of four donors (each donor is represented by a different colour). A one-way ANOVA test was carried out (* p < 0.05).